News
Cosmos Holdings CEO Greg Siokas Converts an Additional $1.0 Million of Debt into Common Stock at $6.00 Per Share
Cosmos Holdings CEO Greg Siokas Converts an Additional $1.0 Million of Debt into Common Stock at $6.00 Per Share The conversion price represents a premium to market July 16, 2021 09:38 ET http://schema.org/Organization">| Source: Cosmos Holdings CHICAGO, July 16, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution network, is pleased to announce that Mr. Greg Siokas, Chief Executive Officer, has further reduced the ...
Cosmos Holdings Signs Exclusive Distribution Agreement with Mediprovita GbR
Cosmos Holdings Signs Exclusive Distribution Agreement with Mediprovita GbR for Launch of Sky Premium Life Products in Germany and Austria   Thu, July 8, 2021, 4:25 PM    First Phase Launches Sky Premium Life Products on Amazon and eBay; Second Phase Launch Includes Brick & Mortar Stores Continues to Expand its Network of European Distribution Partners; Plans to Enter into Additional European, Asian and New Global Markets in 2H 2021 CHICAGO, July 08, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the “Company") (OTCQX: COSM), an international pharmaceutical company with a ...
Cosmos Holdings Appoints Finance Veteran Alexi Papaconstantinou to its Advisory Board
  Cosmos Holdings Appoints Finance Veteran Alexi Papaconstantinou to its Advisory Board   July 01, 2021 09:15 ET http://schema.org/Organization">| Source: Cosmos Holdings   CHICAGO, July 01, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution network, today announced that it has appointed finance veteran Alexi Papaconstantinou to the Company's Advisory Board. Mr. Papaconstantinou is a capital markets veteran and brings over 20 years of experience in investment ...
Cosmos Holdings CEO Greg Siokas Converts $3.0 Million of Debt into Common Stock at $6.00 Per Share
Cosmos Holdings CEO Greg Siokas Converts $3.0 Million of Debt into Common Stock at $6.00 Per Share The conversion price represents a premium to market June 28, 2021 09:25 ET http://schema.org/Organization">| Source: Cosmos Holdings   CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution network, is pleased to announce that Mr. Greg Siokas, Chief Executive Officer, has reduced the debt of the ...
Cosmos Holdings Provides First Quarter 2021 Business Update; Reports 89% Year-Over-Year and 60% Sequential Increase in Nutraceutical Business
Cosmos Holdings Provides First Quarter 2021 Business Update; Reports 89% Year-Over-Year and 60% Sequential Increase in Nutraceutical Business May 18, 2021 09:00 ET http://schema.org/Organization">| Source: Cosmos Holdings   CHICAGO, May 18, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution network, today provided a business update and reported financial results for the first quarter ended March 31, 2021. Greg Siokas, Chief Executive Officer ...
Photo
David E. Gutierrez
Head of PR, IR
and Corporate Development

Join our mailing list to stay up to date.

Cosmos-logo